AI | pharmaphorum

AI

Digital

pharmaphorum podcast Episode 236, Tarek Samad, Lundbeck

An AI supercomputer and discovering next-gen brain disorder ...

Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.

Patients

The humans the algorithms can't reach

Patients don’t start, stay on, or return to therapy because they receive a notification at the right time.

Sales & Marketing

Doctors and medical affairs round a table in discussion

Breaking tradition to reimagine medical affairs workflows fo...

To stay relevant, medical affairs teams must adapt how they work to meet new demands with greater agility and efficiency.

R&D

Beyond good intentions: How life sciences can prove its read...

While support for reducing animal use has never been stronger, the path to broad adoption is steep and complex.

R&D

Big promises, hard work: What 2026 will demand from pharma

Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through.

Digital

Balancing global consistency and local nuance: EVERSANA on A...

The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre

An AI supercomputer and discovering next-gen brain disorder ...

The humans the algorithms can't reach

Breaking tradition to reimagine medical affairs workflows fo...

Beyond good intentions: How life sciences can prove its read...

Big promises, hard work: What 2026 will demand from pharma

Balancing global consistency and local nuance: EVERSANA on A...

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

AI

Editor's Picks